Protein kinases have been important targets for drug discovery, with more than 25 small molecules approved by the FDA and hundreds more in clinical testing phases to treat many diseases, including cancer, autoimmune disorders, and inflammatory conditions [84]. Here, WEE1 is linked to cancer.